Philippe Guinot is a medical doctor and an anesthetist. He holds a Ph.D. in life sciences and is the author of numerous international scientific articles. From 1977 to 1994, he pursued his career in the pharmaceutical industry in business and drug development, working for several international laboratories in Switzerland, France, Germany and the UK. During this time, Dr. Guinot oversaw the development of new drugs, several of which are marketed today. He was appointed Adjunct Professor of Medicine at the University of California, Davis, from 1992 to 1996, then managed three U.S. and French biotechnology companies in France. He joined Crédit Agricole Private Equity in 2001 as Senior Partner, where he created and managed successfully the firm's Biotechnology and Life Sciences investments, with a positive financial return. He started his own consultancy company in 2011 as strategic and fund raising advisor, and he serves on the boards of several biotech companies (listed and private). Philippe Guinot is a medical doctor and an anesthetist. He holds a Ph.D. in life sciences and is the author of numerous international scientific articles. From 1977 to 1994, he pursued his career in the pharmaceutical industry in business and drug development, working for several international laboratories in Switzerland, France, Germany and the UK. During this time, Dr. Guinot oversaw the development of new drugs, several of which are marketed today. He was appointed Adjunct Professor of Medicine at the University of California, Davis, from 1992 to 1996, then managed three U.S. and French biotechnology companies in France. He joined Crédit Agricole Private Equity in 2001 as Senior Partner, where he created and managed successfully the firm's Biotechnology and Life Sciences investments, with a positive financial return. He started his own consultancy company in 2011 as strategic and fund raising advisor, and he serves on the boards of several biotech companies (listed and private).

pharma